Annual Total Long Term Liabilities
$146.53 M
+$2.29 M+1.59%
December 1, 2024
Summary
- As of March 12, 2025, TBPH annual total long term liabilities is $146.53 million, with the most recent change of +$2.29 million (+1.59%) on December 1, 2024.
- During the last 3 years, TBPH annual total long term liabilities has fallen by -$508.27 million (-77.62%).
- TBPH annual total long term liabilities is now -77.62% below its all-time high of $654.80 million, reached on December 31, 2021.
Performance
TBPH Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$146.53 M
-$485.00 K-0.33%
December 1, 2024
Summary
- As of March 12, 2025, TBPH quarterly total long term liabilities is $146.53 million, with the most recent change of -$485.00 thousand (-0.33%) on December 1, 2024.
- Over the past year, TBPH quarterly long term liabilities has stayed the same.
- TBPH quarterly long term liabilities is now -78.39% below its all-time high of $677.95 million, reached on June 30, 2022.
Performance
TBPH Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TBPH Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.6% | 0.0% |
| 3 y3 years | -77.6% | 0.0% |
| 5 y5 years | -71.9% | -77.4% |
TBPH Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.6% | +7.0% | -78.4% | +7.0% |
| 5 y | 5-year | -77.6% | +7.0% | -78.4% | +7.0% |
| alltime | all time | -77.6% | +2634.3% | -78.4% | +2634.3% |
Theravance Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $146.53 M(+1.6%) | $146.53 M(-0.3%) |
| Sep 2024 | - | $147.02 M(+1.1%) |
| Jun 2024 | - | $145.39 M(+0.4%) |
| Mar 2024 | - | $144.78 M(+0.4%) |
| Dec 2023 | $144.24 M(+5.4%) | $144.24 M(+1.5%) |
| Sep 2023 | - | $142.09 M(+0.1%) |
| Jun 2023 | - | $141.92 M(+0.1%) |
| Mar 2023 | - | $141.81 M(+3.6%) |
| Dec 2022 | $136.88 M(-79.1%) | $136.88 M(-2.8%) |
| Sep 2022 | - | $140.79 M(-79.2%) |
| Jun 2022 | - | $677.95 M(+2.3%) |
| Mar 2022 | - | $662.61 M(+1.2%) |
| Dec 2021 | $654.80 M(+0.9%) | $654.80 M(-0.9%) |
| Sep 2021 | - | $660.62 M(-0.3%) |
| Jun 2021 | - | $662.50 M(+0.1%) |
| Mar 2021 | - | $661.83 M(+1.9%) |
| Dec 2020 | $649.24 M(+24.6%) | $649.24 M(-3.0%) |
| Sep 2020 | - | $669.45 M(+1.4%) |
| Jun 2020 | - | $660.09 M(-0.8%) |
| Mar 2020 | - | $665.30 M(+27.7%) |
| Dec 2019 | $520.96 M | $520.96 M(+0.3%) |
| Sep 2019 | - | $519.32 M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $519.53 M(-2.2%) |
| Mar 2019 | - | $530.98 M(+3.4%) |
| Dec 2018 | $513.27 M(+94.7%) | $513.27 M(+81.8%) |
| Sep 2018 | - | $282.38 M(-3.8%) |
| Jun 2018 | - | $293.50 M(-5.8%) |
| Mar 2018 | - | $311.52 M(+18.1%) |
| Dec 2017 | $263.67 M(+10.0%) | $263.67 M(+4.1%) |
| Sep 2017 | - | $253.26 M(+3.1%) |
| Jun 2017 | - | $245.66 M(+0.2%) |
| Mar 2017 | - | $245.11 M(+2.2%) |
| Dec 2016 | $239.75 M(+3062.6%) | $239.75 M(+1743.4%) |
| Sep 2016 | - | $13.01 M(+57.7%) |
| Jun 2016 | - | $8.25 M(+0.7%) |
| Mar 2016 | - | $8.19 M(+8.0%) |
| Dec 2015 | $7.58 M(+12.7%) | $7.58 M(+0.7%) |
| Sep 2015 | - | $7.53 M(+2.8%) |
| Jun 2015 | - | $7.33 M(+5.7%) |
| Mar 2015 | - | $6.93 M(+3.1%) |
| Dec 2014 | $6.73 M(+25.5%) | $6.73 M(+11.1%) |
| Sep 2014 | - | $6.06 M(+5.9%) |
| Jun 2014 | - | $5.72 M(+3.2%) |
| Mar 2014 | - | $5.54 M(+3.4%) |
| Dec 2013 | $5.36 M | $5.36 M |
FAQ
- What is Theravance Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Theravance Biopharma?
- What is Theravance Biopharma annual total long term liabilities year-on-year change?
- What is Theravance Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Theravance Biopharma?
- What is Theravance Biopharma quarterly long term liabilities year-on-year change?
What is Theravance Biopharma annual total long term liabilities?
The current annual total long term liabilities of TBPH is $146.53 M
What is the all time high annual total long term liabilities for Theravance Biopharma?
Theravance Biopharma all-time high annual total long term liabilities is $654.80 M
What is Theravance Biopharma annual total long term liabilities year-on-year change?
Over the past year, TBPH annual total long term liabilities has changed by +$2.29 M (+1.59%)
What is Theravance Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of TBPH is $146.53 M
What is the all time high quarterly long term liabilities for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total long term liabilities is $677.95 M
What is Theravance Biopharma quarterly long term liabilities year-on-year change?
Over the past year, TBPH quarterly total long term liabilities has changed by $0.00 (0.00%)